Article

CDC Finds mRNA COVID-19 Vaccines Provide More Immunity Than Prior Infection

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.

The results from a CDC study show that mRNA COVID-19 vaccines are associated with significantly more immunity than a prior COVID-19 infection.

“[These] data provides powerful evidence that vaccinations offer superior protection against COVID-19 than relying on natural immunity alone,” Shaun Grannis, MD, professor of family medicine at Indiana University School of Medicine, said in a statement.

Overall, those who were unvaccinated with a prior COVID-19 infection were 5 times more likely to be hospitalized from COVID-19 than those who were vaccinated.

The investigators analyzed the number of unvaccinated individuals who tested positive for COVID-19 more than 3 months before hospitalization from COVID-19 and those who were vaccinated with either the Moderna or Pfizer vaccine and were not diagnosed with COVID-19 prior to hospitalization.

Investigators from the CDC’s VISION Network gathered data for 7000 who fit the criteria of the study in 9 different states.

The results also showed that mRNA vaccines were nearly 20 times more effective at preventing hospitalizations from COVID-19 for individuals older than aged 65 years than a prior infection alone.

Reference

COVID vaccines 5 times more effective at preventing COVID-related hospitalization than prior infection alone. EurekAlert. News release. October 29, 2021. Accessed November 1, 2021. https://www.eurekalert.org/news-releases/933238

Related Videos
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought